4
Changes in Ownership
Tyra Biosciences, Inc. Filed Acc 0001209191-23-039807
Chief Executive Officer sold 24,190 shares at an average $17.01 ($411,512)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harris Todd Chief Executive Officer | 2023-06-22 | Sale 10b5-1 | −2,978 | $16.98 | $50,558 | 1,622,488 | D |
| Harris Todd Chief Executive Officer | 2023-06-22 | Sale 10b5-1 | −500 | $17.39 | $8,693 | 1,621,988 | D |
| Harris Todd Chief Executive Officer | 2023-06-23 | Sale 10b5-1 | −14,231 | $16.78 | $238,798 | 1,607,757 | D |
| Harris Todd Chief Executive Officer | 2023-06-23 | Sale 10b5-1 | −6,481 | $17.51 | $113,464 | 1,601,276 | D |
| Open-market sales · 24,190 sh · avg $17.01 · $411,512 | |||||||
Loading xslF345X04/doc4.xml…